Swiss investment firm Sectoral Asset Management has launched a new biotech strategy, the Variopartner SICAV – Sectoral Biotech Opportunities Fund with initial assets of over $50m (€44.1m). The fund invests in innovative biotech companies and focuses on small and mid caps. Its portfolio consists of 30 high conviction positions and the stock selection applies a bottom-up approach. […]
Loading ...
Odey’s Geoff Marson joins Hamburg Summit 
Fisch AM’s Martin Haycock revisits case for convertibles at Copenhagen Roundtable 
MainFirst’s Jan-Christoph Herbst joins Copenhagen Roundtable 
Steve Johnstone of Janus Henderson Investors outlines the market neutral approach at Hamburg Summit 
Mirae Asset GI CIO to attend December Stockholm Forum More news
